Peter Luijten started as vice-dean for the strategic theme Life Sciences
It all comes down to people. Speaking this simple truth brings a gleam to the eyes of Peter Luijten, the newly appointed Vice Dean for the strategic theme Life Sciences. It is at the core of what he hopes to achieve in his new position: connecting people by their shared interests. 鈥淯trecht offers all flavours of life science research within a few square kilometres, making collaboration relatively easy. That does not automatically mean everything is optimally connected鈥 he says, summarizing both the strength and the challenge for the strategic theme. 鈥淭here is tremendous opportunity in Utrecht. When we join forces and resources, life sciences research in Utrecht can be more than the sum of individual players, it will be a name to reckon with鈥 he adds. A long career as bridge-builder in the life sciences will help Luijten tackle this new challenge.
鈥淚 dislike organisations in which everything has to be run by a supervisor鈥, Luijten starts. 鈥淕iving researchers freedom to experiment without too many restrictions can result in great science鈥 he adds. He makes an effort to look at ongoing research and connects people based on their potential shared interests. 鈥淚t鈥檚 a bit of a dogma, but true innovation is found where research areas overlap. Creating connections truly adds value to research鈥 he concludes. 鈥淭hat is not always a given, it takes a lot of effort鈥.
Putting Utrecht in the spotlight
The first item on Luijtens agenda is strengthening the overarching story about Life Sciences research in Utrecht. 鈥淭he strategic theme already achieved some great successes. We need to tell these stories so no-one needs to wonder: What is life sciences in Utrecht all about?鈥 First-hand experience at the other end of the table at the NWO was an eye-opener for Luijten. 鈥淪eeing funding proposals from across the country for large-scale infrastructure, I noticed there were many great proposals from Utrecht, but there was limited connection between them鈥. Strengthening these connections was already an item when he was scientific director of the strategic theme, as vice dean he can really make some strides. 鈥淚f we truly want to show our face, we need to demonstrate what we鈥檙e good at, for instance large scale infrastructure鈥
We have many highly esteemed researchers in Utrecht, but quite often they are cited outside of the context of Utrecht Life Sciences
Successful collaboration starts with a shared identity. As an example Luijten mentions the procedures for appointing a professor. 鈥淭raditionally, professor appointments are organised entirely by the faculties. If you want professors to feel part of the larger life sciences community, a joint professor plan would ideally be organised by the strategic theme. That would cement the bigger picture top-down鈥. The programme board of the strategic theme, in which faculties are equally represented, would be perfectly suited to initiate this. 鈥淛oint professorships are potentially an aspect of this as well, also to better facilitate interdisciplinarity鈥 Luijten continues. 鈥淢y experience at UMC Utrecht taught me that moving away from a rigid organisational structure towards one with more flexible 鈥榝ocus areas鈥 takes time. But we are already reaping the benefits. Underscoring the overarching research themes really helps bring focus into the research effort.鈥 At UMC Utrecht this brought about a new way of thinking, with researchers identifying themselves with the broader teams rather than just their own research group. Letting go of existing structures and determining a new focus is a challenge to which Peter Luijten is well suited.
Background
Peter Luijten earned his PhD as a chemical physicist in 1984 on the subject of Nuclear Magnetic Resonance. At the time, the first MRI machines were just entering the market and as a highly skilled academic Luijten was hired by Philips as an expert. While not uncommon nowadays, being hired by a company as an academic was a strange occurrence back then. 鈥淢y friends in Amsterdam told me it was simply 鈥榥ot-done鈥; they thought I鈥檇 sold my soul to the devil鈥 Luijten laughs. 鈥淎nd at a production department no less, how low could I go?鈥. The freedom he had to develop expertise at Philips was an eye-opener for him. 鈥淭heir motto was: You鈥檙e the expert, so you call the shots. I was soon made responsible for a small team of independent employees from a variety of fields, who were charged with setting up collaborative efforts with academic institutions.鈥 Building partnerships based on a fixed assignment is a good fit for Luijten, who has also spent five years working in the United States. 鈥淚 went there to connect with academic hospitals in the field of imaging. That often resulted in interesting scientific discussions, but I still had to keep an eye on our business interests.鈥 Luijten jokingly refers to himself as 鈥榓 glorified salesman鈥 at the time, but he also says: 鈥淲e sold something based on the benefit it had to offer, with a clear social interest. I learned a lot from that experience, looking behind the scenes at many major academic hospitals, and in the process I forged partnerships that are still going strong today.鈥
Scientists are a collection of headstrong and unique individuals, and you need to have a sense of how to deal with them.
Upon his return to the Netherlands, Luijten was assigned his own research group at UMC Utrecht, with a focus on MRI at extremely high magnetic resonances: the 鈥7 Tesla鈥 group. 鈥淎round 2006, the government invested a huge amount in research, a bit like they are now with the growth fund. In the field of Life Sciences, the investments went to areas such as pharmaceutical development, regenerative medicine and the Center for Translational Molecular Medicine (CTMM). In addition to leading his group at UMC Utrecht, Luijten was also named Scientific Director of the CTMM. 鈥淭hat activity has a lot of similarities to the strategic theme. I鈥檝e always enjoyed being able to find something in research groups that make them stronger together.鈥
Together in the common interest
More and more knowledge institutions today are choosing to work together on convergent fields of study, and building alliances based on shared interests. 鈥淗ere in Utrecht, we have every field of expertise, so we practically have partnerships offered up on a platter鈥, Luijten says. But we have to pay attention that we don鈥檛 look for connections simply for the sake of making connection; it has to lead to something useful.鈥 Luijten also sees a false contrast between applied and fundamental research. 鈥淚n the Life Sciences, research is always inspired by society one way or another. Even fundamental research leads to insights and has intrinsic value.鈥 To Luijten, it is understandable that the applicability of research is considered when awarding grants, but he does notice that there are some disadvantages. 鈥淵ou can鈥檛 always describe applicability in concrete terms. By explicitly asking about it as a grant provider, you run the risk of encouraging applicants to make ridiculous statements, especially among younger researchers: we have to give them leeway for their research.鈥 Just as he once received more freedom at Philips, and therefore felt less pressure to meet external preconditions, he now advocates giving researchers more freedom in their work. 鈥淵ou can see that spirit in a lot of small companies and start-ups. The idea that we can use that freedom to build public-private partnerships really appeals to mee.鈥 Internationalisation presents a similar mix of challenges and opportunities: 鈥淪pontaneous collaborations produce some beautiful results, but reinforcing and expanding existing structures would make a collaboration even more effective.鈥 Collaboration is therefore the key word.
Success is when we can truly make a difference
Meaningful research is extremely important for Luijten. 鈥淭hat means you need to look at your findings with a critical eye, and not try to promote them purely for the validation鈥, he says. 鈥淲e鈥檙e doing that much better today. Take the increasing ties to epidemiological research, for example, which has made evidence-based medicine standard practice today.鈥 Research also has value outside of the walls of academia. Companies are bringing academic developments directly to the patient, for example. 鈥淵ou definitely need to make agreements regarding the business side of things鈥, Luijten agrees.
I don鈥檛 believe in the model where the university throws something over the fence to the business community. I鈥檇 rather see that fence taken down.
In Luijten鈥檚 research group, the borders between institutions are regularly erased. In the lab, researchers from the hospital stand side-by-side with their colleagues from several different companies. 鈥淚 believe that 鈥榤easuring is knowing鈥, but I prefer to measure success by the stories. Take the Regenerative Medicine domain in Utrecht, for example: it鈥檚 earned an excellent reputation in the Netherlands and abroad, as has One Health. That鈥檚 not only because of the strategic theme; in the end, it鈥檚 the result of the people鈥檚 hard work. Setting a good framework and then letting people do what they want to do; that鈥檚 what I call a success story.鈥 The first steps have already been taken, and now we can expand our efforts and eventually show that the research has had an impact, and that we鈥檝e solved some important problems to the benefit of people outside of Utrecht Science Park. 鈥淚f we can communicate that with some good stories, then I鈥檒l be satisfied.鈥 Perhaps it鈥檚 a result of the year Luijten spent working in science journalism after earning his PhD, but he is enthusiastic about listening to stories and passing them on: 鈥淎 good story tells more than 1,000 success parameters.鈥

Vision of the future
Over the next few months, Luijten will ensure a warm transfer of his responsibilities as a Division Head at UMC Utrecht in order to gradually focus more on his duties as Vice Dean of Life Sciences. 鈥淚 look forward to building on a future where not only the three faculties collaborate much more often, but where we look for connections to the Prinses M谩xima Centre, the Hubrecht Institute and businesses on campus.鈥 If it were up to Luijten, Utrecht Life Sciences would become one big bulwark of research. 鈥淲hen I look at institutes in the US, I see integration across all of the disciplines, from the clinic to basic sciences; we could be moving in that direction too.鈥 As an example, he mentions the distance between the three faculties, especially the Faculty of Medicine. 鈥淚t鈥檚 often identified with the hospital, but I鈥檇 rather make it more simple: when you talk about Life Sciences, you should mean 鈥榚veryone in Utrecht鈥.鈥 When it comes to research, it shouldn鈥檛 matter which organisational unit someone is assigned to. 鈥淚n collaborative projects between UMC Utrecht and the Prinses M谩xima Centre, everyone works on the same subject, and it doesn鈥檛 matter who pays your salary. That sense of belonging to a campus, the Utrecht community; that鈥檚 what I鈥檇 like to infuse in Utrecht.鈥 Anything else? 鈥淚鈥檝e been playing music for my whole life, and I hope to keep doing it for a long time to come. Over the next few years, I hope to bring music to Utrecht Life Sciences as well.鈥